Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.

Researchers say a generic version could be made for just $25 per person a year.

Capitalism kills.

@luckytran I'm curious what the PBMs will negotiate that price down to. There's a 0% chance anyone will ever spend $28k on a single dose, but will the PBMs negotiate it down under $10k? Under $1k?
@pmc @luckytran It's just like rich folks paying ridiculous amounts for super new cutting-edge tech (like the laser disc of the early 90s) and such. Of course, AIDS kills, so it won't just be a hobby/ status symbol. But I'm guessing a handful of rich people will buy it.